Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (11719)	10/2/2018 4:04:39 PM
From: Miljenko Zuanic	Respond to of 12215

<Though I'll agree with the bearish guy that we could have been given more data than we were...> Why they did not posted slides from 5211 conference presentation???? I agree, anabolic-bone benefit will be important for prospective partner. As well as candidate IP status (which is weak at the best).

To: tuck who wrote (11719)	10/2/2018 11:57:24 PM
From: scaram(o)uche	Respond to of 12215

>> Is that plus the human data so far enough for a partner? << I feel the same way. Given what we've heard from company, I would expect a back-end heavy deal. Like MZ, I'm going to be big time ticked if a partner doesn't materialize. I could see Lian getting too excited by early contacts going nowhere...... MZ's concern. But I don't read him as the sort who would hide bad data. This, for me, is part of a larger issue. I expected pharma to panic, to start to partner/munch where and when they could, given the focus on price increases. Hasn't materialized.